Annual report
2269.TEDINET S100PUPX
Period2017-04-01 → 2018-03-31
Filed2022-12-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100DGCD.
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.24T | 2017-04-01 → 2018-03-31 | Cons. | Net sales |
| Revenue | ¥1.24T | 2016-04-01 → 2017-03-31 | Cons. | Net sales |
| Revenue | ¥1.22T | 2015-04-01 → 2016-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.16T | 2014-04-01 → 2015-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.15T | 2013-04-01 → 2014-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥94.7bn | 2017-04-01 → 2018-03-31 | Cons. | Operating income |
| Operating income | ¥88.4bn | 2016-04-01 → 2017-03-31 | Cons. | Operating income |
| Ordinary income | ¥95.9bn | 2017-04-01 → 2018-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥88.8bn | 2016-04-01 → 2017-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥81.8bn | 2015-04-01 → 2016-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥53.6bn | 2014-04-01 → 2015-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥39.1bn | 2013-04-01 → 2014-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥91.1bn | 2017-04-01 → 2018-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥89.2bn | 2016-04-01 → 2017-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥61.3bn | 2017-04-01 → 2018-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥60.8bn | 2016-04-01 → 2017-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥62.6bn | 2015-04-01 → 2016-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥30.9bn | 2014-04-01 → 2015-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥19.1bn | 2013-04-01 → 2014-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥62.0bn | 2017-04-01 → 2018-03-31 | Cons. | Profit loss |
| Net income | ¥61.2bn | 2016-04-01 → 2017-03-31 | Cons. | Profit loss |
| Total assets | ¥927.5bn | at 2018-03-31 | Cons. | Assets |
| Total assets | ¥883.9bn | at 2017-03-31 | Cons. | Assets |
| Total assets | ¥856.1bn | at 2016-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥877.4bn | at 2015-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥779.5bn | at 2014-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥432.4bn | at 2018-03-31 | Cons. | Liabilities |
| Total liabilities | ¥426.7bn | at 2017-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥495.2bn | at 2018-03-31 | Cons. | Net assets |
| Net assets / equity | ¥457.2bn | at 2017-03-31 | Cons. | Net assets |
| Net assets / equity | ¥419.2bn | at 2016-03-31d | Cons. | Net assets |
| Net assets / equity | ¥380.3bn | at 2015-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥328.1bn | at 2014-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.6bn | at 2018-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥24.8bn | at 2017-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥26.9bn | at 2018-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.6bn | at 2017-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥31.5bn | at 2016-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.9bn | at 2015-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥19.2bn | at 2014-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥108.8bn | 2017-04-01 → 2018-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥81.9bn | 2016-04-01 → 2017-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥105.2bn | 2015-04-01 → 2016-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥86.5bn | 2014-04-01 → 2015-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥63.8bn | 2013-04-01 → 2014-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥64.4bn | 2017-04-01 → 2018-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥44.3bn | 2016-04-01 → 2017-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥9.8bn | 2015-04-01 → 2016-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥92.8bn | 2014-04-01 → 2015-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥47.3bn | 2013-04-01 → 2014-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥40.1bn | 2017-04-01 → 2018-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥46.5bn | 2016-04-01 → 2017-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥85.1bn | 2015-04-01 → 2016-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.8bn | 2014-04-01 → 2015-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥18.2bn | 2013-04-01 → 2014-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥422.15 | 2017-04-01 → 2018-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥413.11 | 2016-04-01 → 2017-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥425.06 | 2015-04-01 → 2016-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.79 | 2014-04-01 → 2015-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥129.4 | 2013-04-01 → 2014-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,360.7 | at 2018-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,064.91 | at 2017-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,777.28 | at 2016-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,515.26 | at 2015-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,175.98 | at 2014-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 52.5% | at 2018-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.8% | at 2017-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2016-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2015-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.1% | at 2014-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 13.1% | 2017-04-01 → 2018-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.2% | 2016-04-01 → 2017-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2015-04-01 → 2016-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2014-04-01 → 2015-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2013-04-01 → 2014-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 16,296 | at 2018-03-31 | Cons. | Number of employees |
| Employees | 16,726 | at 2017-03-31 | Cons. | Number of employees |
| Employees | 16,456 | at 2016-03-31d | Cons. | Number of employees |
| Employees | 16,559 | at 2015-03-31d | Cons. | Number of employees |
| Employees | 15,033 | at 2014-03-31d | Cons. | Number of employees |
| Revenue | ¥19.6bn | 2017-04-01 → 2018-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥17.3bn | 2016-04-01 → 2017-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥9.7bn | 2015-04-01 → 2016-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥9.3bn | 2014-04-01 → 2015-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥9.3bn | 2013-04-01 → 2014-03-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥17.5bn | 2017-04-01 → 2018-03-31 | Standalone | Operating income |
| Operating income | ¥15.3bn | 2016-04-01 → 2017-03-31 | Standalone | Operating income |
| Ordinary income | ¥18.0bn | 2017-04-01 → 2018-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥16.2bn | 2016-04-01 → 2017-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥7.9bn | 2015-04-01 → 2016-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.5bn | 2014-04-01 → 2015-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.2bn | 2013-04-01 → 2014-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥18.0bn | 2017-04-01 → 2018-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥16.2bn | 2016-04-01 → 2017-03-31 | Standalone | Income before income taxes |
| Net income | ¥18.0bn | 2017-04-01 → 2018-03-31 | Standalone | Profit loss |
| Net income | ¥16.0bn | 2016-04-01 → 2017-03-31 | Standalone | Profit loss |
| Net income | ¥19.0bn | 2015-04-01 → 2016-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.3bn | 2014-04-01 → 2015-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.8bn | 2013-04-01 → 2014-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥386.8bn | at 2018-03-31 | Standalone | Assets |
| Total assets | ¥421.2bn | at 2017-03-31 | Standalone | Assets |
| Total assets | ¥432.7bn | at 2016-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥489.7bn | at 2015-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥463.4bn | at 2014-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥120.5bn | at 2018-03-31 | Standalone | Liabilities |
| Total liabilities | ¥144.7bn | at 2017-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥266.3bn | at 2018-03-31 | Standalone | Net assets |
| Net assets / equity | ¥276.5bn | at 2017-03-31 | Standalone | Net assets |
| Net assets / equity | ¥283.6bn | at 2016-03-31d | Standalone | Net assets |
| Net assets / equity | ¥273.7bn | at 2015-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥265.5bn | at 2014-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.1bn | at 2018-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2017-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥124 | 2017-04-01 → 2018-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.85 | 2016-04-01 → 2017-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥129.14 | 2015-04-01 → 2016-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.47 | 2014-04-01 → 2015-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.88 | 2013-04-01 → 2014-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥130 | 2017-04-01 → 2018-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥110 | 2016-04-01 → 2017-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥117.5 | 2015-04-01 → 2016-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2014-04-01 → 2015-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2013-04-01 → 2014-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,836.25 | at 2018-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,887.79 | at 2017-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,926.48 | at 2016-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,859.04 | at 2015-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,803.03 | at 2014-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.8% | at 2018-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.6% | at 2017-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.6% | at 2016-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.9% | at 2015-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.3% | at 2014-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.6% | 2017-04-01 → 2018-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.7% | 2016-04-01 → 2017-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2015-04-01 → 2016-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2014-04-01 → 2015-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.9% | 2013-04-01 → 2014-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 152,683,000 | at 2018-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 152,683,000 | at 2017-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 152,683,000 | at 2016-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 76,341,000 | at 2015-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 76,341,000 | at 2014-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 35 | at 2018-03-31 | Standalone | Number of employees |
| Employees | 36 | at 2017-03-31 | Standalone | Number of employees |
| Employees | 34 | at 2016-03-31d | Standalone | Number of employees |
| Employees | 34 | at 2015-03-31d | Standalone | Number of employees |
| Employees | 34 | at 2014-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2017-04-01 → 2018-03-31 | ¥37m |
| Reconciling Itemsreconciling | depreciation | 2017-04-01 → 2018-03-31 | ¥315m |
| Reconciling Itemsreconciling | revenue | 2017-04-01 → 2018-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2017-04-01 → 2018-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2018-03-31 | ¥53.4bn |
| Reconciling Itemsreconciling | segment profit | 2017-04-01 → 2018-03-31 | −¥541m |
| Foodreportable segment | capex | 2017-04-01 → 2018-03-31 | ¥66.2bn |
| Foodreportable segment | depreciation | 2017-04-01 → 2018-03-31 | ¥40.2bn |
| Foodreportable segment | revenue | 2017-04-01 → 2018-03-31 | ¥1.07T |
| Foodreportable segment | revenue external | 2017-04-01 → 2018-03-31 | ¥1.07T |
| Foodreportable segment | revenue intersegment | 2017-04-01 → 2018-03-31 | ¥577m |
| Foodreportable segment | segment assets | at 2018-03-31 | ¥661.4bn |
| Foodreportable segment | segment profit | 2017-04-01 → 2018-03-31 | ¥84.2bn |
| Pharmaceuticalsreportable segment | capex | 2017-04-01 → 2018-03-31 | ¥8.4bn |
| Pharmaceuticalsreportable segment | depreciation | 2017-04-01 → 2018-03-31 | ¥6.0bn |
| Pharmaceuticalsreportable segment | revenue | 2017-04-01 → 2018-03-31 | ¥168.5bn |
| Pharmaceuticalsreportable segment | revenue external | 2017-04-01 → 2018-03-31 | ¥167.8bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2017-04-01 → 2018-03-31 | ¥683m |
| Pharmaceuticalsreportable segment | segment assets | at 2018-03-31 | ¥212.7bn |
| Pharmaceuticalsreportable segment | segment profit | 2017-04-01 → 2018-03-31 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2017-04-01 → 2018-03-31 | ¥74.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2017-04-01 → 2018-03-31 | ¥46.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2017-04-01 → 2018-03-31 | ¥1.24T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2017-04-01 → 2018-03-31 | ¥1.24T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2017-04-01 → 2018-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2018-03-31 | ¥874.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2017-04-01 → 2018-03-31 | ¥95.2bn |
| Reconciling Itemsreconciling | capex | 2016-04-01 → 2017-03-31 | ¥60m |
| Reconciling Itemsreconciling | depreciation | 2016-04-01 → 2017-03-31 | ¥227m |
| Reconciling Itemsreconciling | revenue | 2016-04-01 → 2017-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2016-04-01 → 2017-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment assets | at 2017-03-31 | ¥37.9bn |
| Reconciling Itemsreconciling | segment profit | 2016-04-01 → 2017-03-31 | −¥336m |
| Foodreportable segment | capex | 2016-04-01 → 2017-03-31 | ¥59.5bn |
| Foodreportable segment | depreciation | 2016-04-01 → 2017-03-31 | ¥39.9bn |
| Foodreportable segment | revenue | 2016-04-01 → 2017-03-31 | ¥1.08T |
| Foodreportable segment | revenue external | 2016-04-01 → 2017-03-31 | ¥1.08T |
| Foodreportable segment | revenue intersegment | 2016-04-01 → 2017-03-31 | ¥538m |
| Foodreportable segment | segment assets | at 2017-03-31 | ¥630.2bn |
| Foodreportable segment | segment profit | 2016-04-01 → 2017-03-31 | ¥83.0bn |
| Pharmaceuticalsreportable segment | capex | 2016-04-01 → 2017-03-31 | ¥6.2bn |
| Pharmaceuticalsreportable segment | depreciation | 2016-04-01 → 2017-03-31 | ¥5.7bn |
| Pharmaceuticalsreportable segment | revenue | 2016-04-01 → 2017-03-31 | ¥161.6bn |
| Pharmaceuticalsreportable segment | revenue external | 2016-04-01 → 2017-03-31 | ¥160.9bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2016-04-01 → 2017-03-31 | ¥718m |
| Pharmaceuticalsreportable segment | segment assets | at 2017-03-31 | ¥215.8bn |
| Pharmaceuticalsreportable segment | segment profit | 2016-04-01 → 2017-03-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2016-04-01 → 2017-03-31 | ¥65.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2016-04-01 → 2017-03-31 | ¥45.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2016-04-01 → 2017-03-31 | ¥1.24T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2016-04-01 → 2017-03-31 | ¥1.24T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2016-04-01 → 2017-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2017-03-31 | ¥846.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2016-04-01 → 2017-03-31 | ¥88.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,230
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 3 | |
| Net sales (5-year summary) | Prior4YearDuration | 1148076000000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 1161152000000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 1223746000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1242480000000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 1240860000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | 39089000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | 53582000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | 81826000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 88839000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | 95877000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | 19060000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | 30891000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | 62580000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 60786000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | 61278000000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | 26932000000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | 56757000000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | 47750000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 61766000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | 70800000000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 328121000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 380302000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 419152000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 457190000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 495177000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 779461000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 877367000000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 856115000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 883895000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 927544000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 2175.98 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 2515.26 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 2777.28 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 3064.91 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 3360.70 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 129.40 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 209.79 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 425.06 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 413.11 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 422.15 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.411 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.422 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |